Journal Guide

CT, MRI, PET, malignant tumours, multimodal imaging, imaging biomarkers

http://cancerimmunolres.aacrjournals.org/site/misc/about.xhtml

Since its inception in 1976, Cancer Immunology, Immunotherapy (CII) has reported significant advances in the field of tumor immunology.  The journal serves as a forum for new concepts and advances in basic, translational, and clinical cancer immunology and immunotherapy. CII is keen to publish broad-ranging ideas and reviews, results which extend or challenge established paradigms, as well as negative studies which fail to reproduce experiments that support current paradigms, and papers that do succeed in reproducing others’ results in different contexts.In addition to publishing original research articles and reviews, CII also offers the following unique publication formats:·         “Focussed Research Reviews,” published together with a conference meeting report, which provide individual speakers with the opportunity to expand on the ideas and concepts they presented at the conference.·         “Symposia-in-Writing,” which are virtual workshops consisting of a series of complime

Cancer Investigation is one of the most highly regarded and recognized journals in the field of basic and clinical oncology. It is designed to give physicians a comprehensive resource on the current state of progress in the cancer field as well as a broad background of reliable information necessary for effective decision making. In addition to presenting original papers of fundamental significance, it also publishes reviews, essays, specialized presentations of controversies, considerations of new technologies and their applications to specific laboratory problems, discussions of public issues, miniseries on major topics, new and experimental drugs and therapies, and an innovative letters to the editor section. One of the unique features of the journal is its departmentalized editorial sections reporting on more than 30 subject categories covering the broad spectrum of specialized areas that together comprise the field of oncology. Edited by leading physicians and research scientists, these sections make Cancer Investigation the prime resource for clinicians seeking to make sense of the sometimes-overwhelming amount of information available throughout the field. In addition to its peer-reviewed clinical research, the journal also features translational studies that bridge the gap between the laboratory and the clinic. Read More: http://informahealthcare.com/page/cnv/Description.

The Cancer Journal is a bimonthly peer-reviewed journal featuring clinical studies that highlight state-of-the-art applications of medical, surgical, and radiation oncology, either alone or in multidisciplinary approaches. Edited by some of the leading minds in oncology, the journal emphasizes translational research that bridges laboratory research and patient care.

Cancer Letters is an international journal that considers full-length articles and Mini Reviews in the broad area of basic and translational oncology. Additionally, Special Issues highlight topical areas in cancer research. Basic areas of interest to a broad readership of Cancer Letters include the molecular genetics and cell biology of cancer, radiation biology, molecular pathology, hormones and cancer, viral oncology, metastasis, and chemoprevention. The journal places emphasis on experimental therapeutics, particularly targeted therapies for personalized cancer medicine.Cancer Letters now offers online submission for authors. Please submit manuscripts at http://www.ees.elsevier.com/can and follow the instructions on the site.Benefits to authorsWe also provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our author services.Please see our Guide for Authors for information on article submission. If you require any further information or help, please visit our support pages: http://support.elsevier.com

Cancer Medicine is a peer-reviewed, open access, interdisciplinary journal providing rapid publication of research from global biomedical researchers across the cancer sciences, in the areas of, but not limited to, cancer biology, clinical cancer research, and cancer prevention.

Cancer Microenvironment is the official journal of the International Cancer Microenvironment Society (ICMS). It publishes original studies in all aspects of basic, clinical and translational research devoted to the study of cancer microenvironment. Topics include: Regulation of gene expression in the cancer microenvironment: innate and adaptive immunity in the cancer microenvironment, inflammation and cancer: tumor-associated stroma & extracellular matrix, tumor-endothelium interactions (angiogenesis, extravasation), cancer stem cells, the metastatic niche, targeting the tumor microenvironment: preclinical and clinical trials. The publication of reports on clinical trials is highly encouraged.

Cancer Nanotechnology is devoted for applications of nanotechnology to oncology. This journal publishes important original studies in the following areas:

· Basic research on the design and development of nanoparticles for oncology
· Interactions of nanoparticles with cancer cells
· Nanodrug delivery system for prevention and therapy of cancer
· Nanoparticles mediated cancer diagnostic systems
· Nanoparticles for therapy of human cancer
· Clinical trials evaluating nanoceuticals

Cancer Nexus is an open-access, peer-reviewed, international journal that publishes high-quality, innovative research in the field of cancer research from clinicians, biomedical scientists, and bioinformatics engineers around the world. The journal focuses on the cutting-edge diagnosis and treatment and mechanism research in the clinical, basic and translational directions of oncology, and focuses on the cross-application of artificial intelligence in cancer clinical and basic research, aiming to establish a bridge of communication between clinical, laboratory and artificial intelligence. The journal is also interested in novel anti-tumor drugs, especially the rational design, screening and efficacy evaluation of AI-assisted anti-tumor drugs.

Cancer Nexus publishes Original Articles, Viewpoint, Case report, Review and Editorial. The journal will consider manuscripts in various fields of cancer and specific areas of interest, including but not limited to clinical trials of novel anti-cancer therapies, clinical epidemiology of cancer based on big data, AI-assisted translational cancer research, minimally invasive and non-invasive integrated diagnosis and treatment technology, cancer bioinformatics, cancer immunology and tumor vaccine development, tumor gene therapy, tumor targeted therapy, cancer omics research, mechanism research on tumor development, development and metastasis.

Cancer Nursing is an international journal providing information on cancer nursing research and care. The primary market is clinical practitioners in cancer nursing who depend on the journal for the excellent research presented in its articles which address the spectrum of problems arising in the care and support of cancer patients.Each bimonthly issue of Cancer Nursing; addresses the whole spectrum of problems arising in the care and support of cancer patients;prevention and early detection, geriatric and pediatric cancer nursing, medical and surgical oncology, ambulatory care, nutritional support, psychosocial aspects of cancer, patient responses to all treatment modalities, and specific nursing interventions. The journal offers unparalleled coverage of cancer care delivery practices worldwide, as well as groundbreaking research findings and their practical applications. For more information, visit www.cancernursingonline.com.

Cancer Prevention Research, the newest journal from the American Association for Cancer Research, is devoted exclusively to cancer prevention. The journal publishes important original studies, reviews, and perspectives within the major topic areas of oncogenesis, risk factors and risk assessment, early detection research, and chemopreventive and other interventions, including the basic science behind them. Cancer Prevention Research comprises preclinical, clinical and translational research, with special attention given to molecular discoveries and an emphasis on building a translational bridge between the basic and clinical sciences.

Cancer Research is the most frequently cited cancer journal in the world. The journal publishes original studies, reviews, and opinion pieces offering significance and broad impact to a diverse audience spanning basic, preclinical, clinical, prevention and epidemiological research. Cancer Research seeks manuscripts that offer pathobiological and translational impact to inform the personal, clinical, and societal problems posed by cancer. The main scope of the Journal is captured in its primary subsections, which focus on molecular and cellular pathobiology, tumor and stem cell biology, therapeutics and targets, microenvironment and immunology, prevention and epidemiology, and integrated systems and technology.